The Claim
Twelve weeks of supervised exercise therapy significantly reduces mRNA expression of polymorphonuclear elastase by 48% and myeloperoxidase by 39% in peripheral blood mononuclear cells of patients with symptomatic peripheral artery disease, independent of changes in walking ability or muscle power.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with symptomatic peripheral artery disease, 12 weeks of supervised exercise therapy reduces the levels of two inflammatory markers—polymorphonuclear elastase and myeloperoxidase—in blood cells, regardless of whether walking ability or muscle strength improves.
See the scientific wording
Supervised exercise therapy for 12 weeks significantly reduces mRNA expression of polymorphonuclear elastase by 48% and myeloperoxidase by 39% in peripheral blood mononuclear cells of patients with symptomatic peripheral artery disease, independent of improvements in walking ability or muscle power, suggesting a direct association between exercise and systemic inflammatory marker reduction.
Regular physical activity reduces the activity of immune cells called neutrophils, causing them to produce less of two inflammatory proteins inside their genetic code, even when muscle strength and walking ability do not improve.
What the research says
1 studyAfter 12 weeks of supervised exercise, people with leg artery disease had lower levels of two key inflammation proteins in their blood—even if their walking didn’t get better. This suggests exercise fights inflammation in a way that’s separate from just making muscles stronger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.